Alzheon Obtains $1,300,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9c261bfe-ef34-4464-a4c7-d14bbceefc3e - Date
2/29/2016 - Company Name
Alzheon - Mailing Address
111 Speen Street Framingham, MA 01701 USA - Company Description
Alzheon is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders. - Website
http://www.alzheon.com - Transaction Type
Debt - Transaction Amount
$1,300,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 3 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
